Amylyx gets FDA approval for Relyvrio to treat ALS in adults

By NS Healthcare Staff Writer 30 Sep 2022

Relyvrio, previously known as AMX0035 in the US, is an oral, fixed-dose combination therapy intended for the treatment of adults with ALS, and its FDA approval is supported by data from the CENTAUR clinical trial

Pharmaceuticals

Nutraceuticals

Amylyx gets FDA approval for Relyvrio to treat ALS in adults

MTE: THE NEXT-GENERATION WELLNESS DRINK

‘Break the Ice’ This Winter With The Launch....

Dictador announces the first robot CEO in a....

NUTRISHOP® Gets Real About Gut Health

Pharmaceuticals

Sanofi, Regeneron’s Dupixent approved in US to treat prurigo nodularis
29 Sep 22

Gilead makes progress in fight against alleged counterfeit HIV drug network
29 Sep 22

ArsenalBio and Genentech team up to identify T-Cell therapies for oncology
28 Sep 22

Patient Care

Medlab Middle East generated business worth AED469 million during the 2022 exhibition in Dubai
28 Sep 22

GSK, Microsoft partner with CHDS Nepal on disease surveillance project
22 Sep 22

bluebird bio gets FDA approval for Skysona to treat cerebral adrenoleukodystrophy
19 Sep 22

Nutraceuticals

AMERICAN EGG BOARD: Eggs are a “Healthy Food” in New Proposed FDA Definition
29 Sep 22

Parker’s Plant Based Foods Introduces Quad Protein Smoothie With Revolutionary Prebiotic
22 Sep 22

Abstinence Spirits launches its non-alcoholic Spirits and Aperitifs direct to consumers in the US
22 Sep 22

NS Healthcare is using cookies

Sanofi, Regeneron’s Dupixent approved in US to treat prurigo nodularis29 Sep 22

Gilead makes progress in fight against alleged counterfeit HIV drug network29 Sep 22

ArsenalBio and Genentech team up to identify T-Cell therapies for oncology28 Sep 22

Medlab Middle East generated business worth AED469 million during the 2022 exhibition in Dubai 28 Sep 22

GSK, Microsoft partner with CHDS Nepal on disease surveillance project 22 Sep 22

bluebird bio gets FDA approval for Skysona to treat cerebral adrenoleukodystrophy 19 Sep 22

AMERICAN EGG BOARD: Eggs are a “Healthy Food” in New Proposed FDA Definition29 Sep 22

Parker’s Plant Based Foods Introduces Quad Protein Smoothie With Revolutionary Prebiotic22 Sep 22

Abstinence Spirits launches its non-alcoholic Spirits and Aperitifs direct to consumers in the US22 Sep 22

OUR TITLES

Digital Therapeutics: Benefits, Challenges, and Future....26 Sep 22

Novo Nordisk teams up with Microsoft....13 Sep 22

WuXi STA opens new oligonucleotide and....07 Jul 22

Merck expands US facility to boost....24 Jun 22

GENFIT to acquire Swiss biotech company....20 Sep 22

EC blocks Illumina’s $7.1bn acquisition of....07 Sep 22

CVS Health to acquire home healthcare....06 Sep 22

Novo Nordisk to acquire Forma Therapeutics....02 Sep 22

AstraZeneca, Gatehouse Bio extend partnership to....09 Sep 22

Moderna to supply additional doses of....01 Aug 22

Bavarian Nordic to supply additional monkeypox....18 Jul 22

GenScript, ACT Therapeutics partner to develop....13 Jul 22

Sanofi, Regeneron’s Dupixent approved in US to treat prurigo nodularis
29 Sep 22

Gilead makes progress in fight against alleged counterfeit HIV drug network
29 Sep 22

ArsenalBio and Genentech team up to identify T-Cell therapies for oncology
28 Sep 22

Medlab Middle East generated business worth AED469 million during the 2022 exhibition in Dubai
28 Sep 22

GSK, Microsoft partner with CHDS Nepal on disease surveillance project
22 Sep 22

bluebird bio gets FDA approval for Skysona to treat cerebral adrenoleukodystrophy
19 Sep 22

AMERICAN EGG BOARD: Eggs are a “Healthy Food” in New Proposed FDA Definition
29 Sep 22

Parker’s Plant Based Foods Introduces Quad Protein Smoothie With Revolutionary Prebiotic
22 Sep 22

Abstinence Spirits launches its non-alcoholic Spirits and Aperitifs direct to consumers in the US
22 Sep 22

Digital Therapeutics: Benefits, Challenges, and Future....
26 Sep 22

Novo Nordisk teams up with Microsoft....
13 Sep 22

WuXi STA opens new oligonucleotide and....
07 Jul 22

Merck expands US facility to boost....
24 Jun 22

GENFIT to acquire Swiss biotech company....
20 Sep 22

EC blocks Illumina’s $7.1bn acquisition of....
07 Sep 22

CVS Health to acquire home healthcare....
06 Sep 22

Novo Nordisk to acquire Forma Therapeutics....
02 Sep 22

AstraZeneca, Gatehouse Bio extend partnership to....
09 Sep 22

Moderna to supply additional doses of....
01 Aug 22

Bavarian Nordic to supply additional monkeypox....
18 Jul 22

GenScript, ACT Therapeutics partner to develop....
13 Jul 22